Recurrent Wheezing in Infants: Risk Factors and Prevention With Probiotics.

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

November 30, 2014

Conditions
Respiratory Tract DiseasesWheezing
Interventions
DRUG

Beclomethasone

The wheezing infants will be using the inhaled corticosteroid beclomethasone 50mcg - 02 jets per day (100mcg/dia).

DRUG

Probiotics

Lyophilized form, each sachet containing 1 g of the probiotic, to be used in addition to milk, juice or yoghurt in the first morning meal once daily for 60 days.

DRUG

Placebo

The placebo will be supplied in the same way with the same organoleptic characteristics of formula with probiotics, 1 g sachet for 60 days, in the juice, milk or yoghurt.

Trial Locations (1)

50670-901

Federal University of Pernambuco, Recife

All Listed Sponsors
collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

lead

Universidade Federal de Pernambuco

OTHER

NCT02113072 - Recurrent Wheezing in Infants: Risk Factors and Prevention With Probiotics. | Biotech Hunter | Biotech Hunter